If a humoral pressor substance is responsible for essential hypertension in man, one of its characteristics should be the ability to constrict the arteriolar bed sufficiently to increase total systemic peripheral resistance, but not sufficiently to reduce cutaneous blood flow. Clinical experience indicates that patients with essential hypertension do not have cold, pale skin reflecting diminished blood flow. More objective studies of total systemic peripheral blood flow in persons with essential hypertension have demonstrated no significant reduction from normal levels (1, 2).
If a humoral pressor substance is responsible for essential hypertension in man, one of its characteristics should be the ability to constrict the arteriolar bed sufficiently to increase total systemic peripheral resistance, but not sufficiently to reduce cutaneous blood flow. Clinical experience indicates that patients with essential hypertension do not have cold, pale skin reflecting diminished blood flow. More objective studies of total systemic peripheral blood flow in persons with essential hypertension have demonstrated no significant reduction from normal levels (1, 2).
This hypothetical pressor substance should also be capable of producing generalized systemic arteriolar constriction without inducing significant constriction or decreased blood flow in a cutaneous capillary bed such as the nailfold. Studies of the nailfold capillary bed in persons with essential hypertension have indicated the absence of significant capillary constriction or decreased capillary blood flow (3, 4) .
Two naturally occurring pressor agents, norepinephrine and angiotonin, when infused intravenously into persons with normal blood pressure, produce changes in the central systemic circulation similar to those found in persons with essential hypertension (5, 6) . The hypertensive state associated with the infusion of norepinephrine however differs markedly from essential hypertension when the circulation in a cutaneous capillary bed such as the nailfold is examined. L-Norepinephrine induces a progressive constriction of this capillary bed as the rate of infusion is increased, so that the nailfold capillary bed is rendered ischemic prior to attainment of hypertensive diastolic arterial blood pressure levels (4) .
The purpose of the present study was to determine the reaction of a cutaneous capillary bed in persons made hypertensive by the infusion of angiotonin and to compare this reaction with that seen in persons with hypertension induced by L-norepinephrine and in persons with essential hypertension. The vascular bed * Present address: Department of Medicine, University of Maryland, Baltimore. 477 of the nailfold of the finger was selected for observation since the capillary loops can be visualized readily for prolonged periods without discomfort to the patient. The nail/old observations indicate that angiotonin, unlike L-norepinephrine, is capable of elevating systemic arterial blood pressure without inducing ischemia of this segment of the cutaneous capillary bed. Evidence was also obtained that the nailfold capillary bed of persons made hypertensive by the intravenous infusion of angiotonin exhibited a hyperreactivity to circulating L-norepinephrine similar to that found in patients with essential hypertension.
Metkod
Eleven hospitalized patients with no evidence of cardiovascular disease, and one patient with generalized arteriosclerosis were studied. No patient was receiving medication known to produce cardiovascular changes. During the observations the subjects were recumbent with two blankets over the trunk and lower extremities. Studies were not performed until the fingers had become warm to the touch. One arm was then abducted approximately 30 ° from the side, with the terminal phalanx of the fourth finger at the level of the sternum. Cedar oil was applied to the base of the nail bed and the finger steadied by a clamp applied along the lateral margins of the phalanx. The terminal capillary loops could thus be readily visualized microscopically when illuminated by a slit lamp. A blood pressure cuff was placed about the opposite arm and an infusion of physiologic saline begun in the antecubital vein in such a manner as not to interfere with auscultatory blood pressure determinations. Following these procedures, 20 minutes or longer were allowed to elapse until the blood pressure had stabilized. If at the end of this period the fingers had become cool, pale, or cyanotic, or if the blood flow through the capillary loops had slowed as visualized microscopically, another 20 minutes were allowed to elapse. If the fingers did not become warm and capillary blood flow did not stabilize at a uniform and rapid rate, no further observations were made. After the control period, a solution of L-norepinephrine, 1 4 V/cc.j or a 4 per cent angiotonin 2 solution in physiologic saline was then substituted for the original saline solution by changing the infusion bottle without disturbing the patient. The rates of the L-norepinephrine or the angiotonin infusions were increased progressively by increments of 10 to 50 per cent at 5 to 15 minutes intervals. With each increment the arterial blood pressure, the pulse rate and the reaction of the terminal capillary loops at the base of the fingernail were recorded. In eight patients, the reaction to the intravenous infusion of L-norepinephrine was studied initially, followed 5 to 15 days later by a similar study of the reaction of the same capillary bed to the intravenous infusion of angiotonin. In three patients, only the reaction to the intravenous infusion of angiotonin was observed. One patient (patient 9) received an initial infusion of angiotonin, followed 15 minutes after discontinuance by a L-norepinephrine infusion.
The minimal quantity of T.-norepinephrine required to initiate a 15 second nailfold capillary constriction, administered as a single rapid intravenous injection, was determined prior to and during the administration of the angiotonin infusions. The method for the determination of this "threshold capillary reactivity" has been described previously (3) .
Alterations of nailfold capillary diameter and blood flow were also observed following the abrupt discontinuation of the infusions of L-norepinephrine or angiotonin. 
RESULTS
The effects of the infusion of L-norepinephrine and of angiotonin on blood pressure, pulse rate, and the capillary bed of the na~old are outlined in Table  I . Prior to the infusion of ang~otonin or L-norepinephrine, intermittent and irregular gaps in blood flow were seen in the arterial segments of the terminal capillary loops. These gaps in capillary blood flow rarely exceeded 2 seconds in duration. The infusion of L-norepinephrine in patients with normal blood pressure produced a progressive increase in the frequency, and subsequently the duration of these periodic gaps in capillary blood flow, until a state of sustained ischemia developed, characterized by the "disappearance" of increasing numbers of capillary loops and by slowing and stagnation of red blood cells in other vessels. As it was usually impossible to visualize the arterial system proximal to the terminal capillary loops, it could not be ascertained whether the normally occurring gaps in capillary blood flow and the ischemia induced by the infusion of L-norepinephrine were due to constriction of the arterial segments of the capillary loops or to constriction of the parent arterioles. An initial ischemic reaction, whereby in a field of fifteen to twenty vessels, two or more capillary loops were rendered invisible, occurred when the T.-norepinephrine infusion had elevated the diastolic blood pressure 6 to 24 ram. Hg (average 16 mm. Hg) above the initial levels. Capillary ischemia thus usually appeared prior to the development of hypertensive diastolic arterial blood pressure levels.
The infusion of angiotonin, like the infusion of L-norepinephrine, produced a rise in systolic, diastolic, and mean arterial pressure. As the rate of infusion of angiotonin was increased, the frequency of the intermittent gaps in capillary blood flow increased, although four of the twelve patients exhibited minimal changes, Table I . The duration of these gaps in blood flow, however, did not increase so that even at the highest rates of angiotonin infusion, with elevation of diastolic blood pressure levels to 90 mm. Hg or above, the capillary loops exhibited no evidence of sustained ischemia. "Disappearance" of terminal capillary loops and slowing or stagnation of clumps of red blood cells in the vascular lumen, as occurred during T.-norepinephrine infusions, was not seen during angiotonin infusions. One exception was noted in the patient with diabetes mellitus recovering from exogenous protamine zinc hyperinsulinism.
Prior to the angiotonin infusions, the "threshold capillary reactivity" to a single rapid intravenous injection of T.-norepinephrine fell between 1.5 and 2.5 7. During the infusion of angiotonin, a significant decrease in the threshold capillary reactivity to L-norepinephrine developed, so that 0.5 to 1.0 "r of L-norepinephrine produced similar vasoconstrictor effects, Table I . This reactivity is similar to that reported for persons with essential hypertension (3) .
Following the abrupt discontinuance of the L-norepinephrine infusion, the naflfold capillary bed dilated gradually in six of the eight patients studied, becoming hyperemic within 3 to 8 minutes with a concomittant cessation of the intermittent gaps in capillary blood flow. A cutaneous flush over the forearms and face was often noted at this time. Capillary dilatation, inter° mittency of capillary blood flow, and the cutaneous flush then gradually returned to the initial state, usually within 5 to 10 minutes after the onset of hyperemia. In contrast, in all subjects studied with the exception of the patient recovering from exogenous hyperinsulinism, the capillary bed of the nailfold returned directly to the original state following the abrupt cessation of the infusion of angiotonin. No cutaneous flush was seen. Fig. 1 is a photomicrograph (X 114) of the capillary bed of the nailfold of a patient with a diastolic arterial blood pressure of 54 mm. Hg. Fig. 2 indicates the ischemic reaction produced during the intravenous infusion of L-norepi-nephrine when the diastolic blood pressure had been elevated to 80 mm. Hg. Fig. 3 depicts the same capillary bed during the intravenous infusion of angiotonin 5 days later, when the initial diastolic blood pressure of 60 mm. Hg. had been elevated to 90 mm Hg. There is no evidence of capillary ischemia.
DISCUSSION
Previous investigators have indicated that pressor agents which severely reduce cutaneous blood flow in relation to their ability to raise arterial blood pressure could scarcely be expected to be concerned in the genesis of essential hypertension (7) . A central systemic hemodynamic state resembling that found in patients with essential hypertension can be produced in persons with normal blood pressure by the infusion of either of two naturally occurring substances, L-norepinephrine or angiotonin. However when L-norepinephrine was infused in persons with normal blood pressure, ischemia of a cutaneous capillary--that of the nailfold---developed prior to the attainment of hypertensive blood pressure levels. Such nailfold capillary ischemia was not seen in persons with essential hypertension, even during the malignant phase of the hypertensive disease (3). These findings parallel the changes in over-all blood flow to the extremities as evidenced by the reduction in forearm blood flow and the markedly decreased heat elimination from the hand during norepinephrine induced hypertension (8) , in contrast to the relatively normal peripheral blood flow and heat elimination found in persons with essential hypertension (1, 2, 6).
Since reactive hyperemia indicates the prior existence of tissue ischemia (9), the frequent occurrence of cutaneous flushing and the reactive hyperemia seen in the nailfold capillary bed following the abrupt discontinuance of the L-norepinephrine infusion is further evidence that norepinephrine significantly curtails skin blood flow. Transient reactive hyperemia following depression of forearm blood flow has previously been reported after discontinuation of noradrenaline infusions (8) .
Angiotonin differed from L-norepinephrine by raising systemic arterial blood pressure without inducing a sustained ischemia of the nailfold capillary bed. The one exception, noted in the patient recovering from exogenous hyperinsulinism, may be attributable to an increase in endogenous epinephrine secretion that is known to occur in this state (10) . The absence of nailfold capillary hyperemia after the abrupt cessation of the angiotonin infusions yielded corroborative evidence of the maintainence of adequate capillary blood flow. Previous objective evidence for normal cutaneous blood flow during angiotonin infusions in man was based upon the absence of a significant reduction of skin temperature (6) .
The effects of L-norepinephrine and angiotonin on nailfold capillary blood flow in man are comparable to those produced in the peripheral circulation in animals. Elevation of arteriaYblood pressure of rabbits with angiotonin, renin, or induced renal hypertension was associated with visible arteriolar constriction in the ear and mesentery, but in contrast to epinephrine and norepinephrine, capillary blood flow and capillary diameter were not decreased (11) (12) (13) (14) . In addition, skin temperature was not reduced significantly during injections of renal extracts which elevated arterial blood pressure, renin thus being unique among all other pressor substances (7). Furthermore, when renin was injected into rabbits with preexisting renal hypertension, the arterial blood pressure was markedly elevated without a concomitant decrease in skin temperature (15) . Dogs also failed to exhibit a consistent change in skin temperature during angiotonin infusions (16) .
The absence of sustained nail/old capillary ischemia, despite the increased frequency of interruptions in capillary blood flow which usually characterized the angiotonin induced hypertension, has often been noted in persons with essential hypertension (3, 4) . By direct microscopic observations, therefore, the nail/old capillary bed in persons with angiotonin-induced hypertension could not be distinguished from that seen in persons with essential hypertension. One rather characteristic alteration of the nail/old capillary vessels in subjects with essential hypertension, in contrast to subjects with normal blood pressure, is the hyperreactivity exhibited to intravenously injected L-norepinephrine (3, 4) . The L-norepinephrine reactivity of the nail/old capillary bed was therefore evaluated in the present group of normotensive subjects prior to and during the angiotonin-induced hypertension. Significant capillary hyperreactivity to norepinephrine was found to develop during the infusion of angiotonin, so that the nailfold vessels in persons with angiotonininduced hypertension remained indistinguishable from that of persons with essential hypertension. Thus from the standpoint of its effects upon the nailfold capillary bed, angiotonin, unlike L-norepinephrine, is one substance which possesses the properties required of the hypothetical humoral pressor substance of essential hypertension.
CONCLUSIONS
Further evidence has been obtained that L-norepinephrine infusions markedly decreases cutaneous capillary blood flow in the nail/old. Sustained ischemia of the capillary bed occurred prior to the attainment of hypertensive diastolic arterial blood pressure levels. Corroborative evidence of this nailfold capillary ischemia was obtained from the capillary reactive hyperemia that followed the abrupt discontinuance of the L-norepinephrine infusions.
The infusion of angiotonin into persons with normal blood pressure did not induce sustained ischemia of the nailfold capillary vessels, even after definite hypertensive diastolic arterial blood pressure levels were attained. Corroboration of the adequacy of nailfold capillary blood flow was obtained by noting the absence of capillary reactive hyperemia foIlowing the abrupt cessation of the angiotonln infusions.
The nailfold capillary bed in persons with angiotonin-induced hypertension could not be distinguished from that of persons with essential hypertension by direct microscopic examination.
During the infusion of angiotonin into subjects with normal cardiovascular systems, the reactivity of the nailfold capillary bed to circulating L-norepinephrine was significantly increased, approaching the levels found in persons with essential hypertension.
From the standpoint of its effects upon the nailfold capillary bed, angiotonin, unlike T.-norepinephrine, is one substance which possesses the properties required of the hypothetical humoral pressor substance of essential hypertension.
